
    
      This study has a randomized, open-label, two-treatment, one-sequence, multiple drug
      administration design. The purpose of this study is as follows; To investigate
      pharmacokinetics, metabolomics and biomarker in healthy elderly subject after ursodeoxycholic
      acid administration
    
  